大型初发系统性红斑狼疮队列中的癌症风险:人口学特征、吸烟与药物的影响
该研究在1668例初发系统性红斑狼疮(SLE)患者中每年评估临床变量与癌症结局,平均随访9年,共发生65例癌症。多因素分析显示总体癌症风险主要与男性及诊断时年龄较大相关,吸烟与肺癌相关,抗疟药与乳腺癌和非黑色素瘤皮肤癌风险呈负相关。
要点
- 吸烟是SLE中尤其肺癌的关键可干预风险因素。
- 总体癌症风险主要与男性性别和SLE诊断时年龄较大相关。
- 抗疟药与乳腺癌及非黑色素瘤皮肤癌风险呈负相关。
核心结论
- 吸烟是SLE中尤其肺癌的关键可干预风险因素。
- 免疫抑制剂除环磷酰胺与非黑色素瘤皮肤癌外,未明确与更高癌症风险相关。
- 抗疟药与乳腺癌和非黑色素瘤皮肤癌风险呈负相关。
- SLE疾病活动度与血液系统癌症风险正相关,与非黑色素瘤皮肤癌风险负相关。
研究设计与样本
- 在初发SLE患者中每年评估临床变量与癌症结局。
- 共纳入1668例患者,平均随访9年。
- 采用多因素风险回归模型,纳入人口学特征、时变药物(糖皮质激素、抗疟药、免疫抑制剂)、吸烟及调整平均SLE疾病活动指数2000评分。
主要发现
- 1668例患者中共发生65例癌症:乳腺癌15例、非黑色素瘤皮肤癌10例、肺癌7例、血液系统癌症6例、前列腺癌6例、黑色素瘤5例、宫颈癌3例、肾癌3例、胃癌2例、头颈癌2例、甲状腺癌2例、直肠癌1例、肉瘤1例、胸腺瘤1例、子宫癌1例。
- 一半癌症(包括所有肺癌)发生于既往或当前吸烟者,而无癌症患者中吸烟者占三分之一。
- 多因素分析显示总体癌症风险主要与男性性别和SLE诊断时年龄较大相关。
- 吸烟与肺癌相关;年龄与乳腺癌风险正相关,抗疟药与乳腺癌风险负相关。
- 抗疟药和较高疾病活动度与非黑色素瘤皮肤癌风险负相关,年龄和环磷酰胺与非黑色素瘤皮肤癌风险正相关;疾病活动度与血液系统癌症风险正相关、与非黑色素瘤皮肤癌风险负相关。
关键数值与推荐
- 总体癌症风险主要与男性性别和SLE诊断时年龄较大相关。
- 吸烟与肺癌风险相关。
- 乳腺癌风险:年龄正相关,抗疟药负相关。
- 非黑色素瘤皮肤癌风险:年龄和环磷酰胺正相关,抗疟药和较高疾病活动度负相关。
- 血液系统癌症风险与疾病活动度正相关。
临床怎么用
- 在SLE管理中应重视吸烟筛查与戒烟干预,尤其针对肺癌风险。
- 对男性及诊断时年龄较大的SLE患者应关注总体癌症风险。
- 使用环磷酰胺者需关注非黑色素瘤皮肤癌风险。
- 抗疟药使用与乳腺癌和非黑色素瘤皮肤癌风险较低相关,但需结合个体情况权衡。
局限性
- 癌症绝对数量较少,需额外随访以巩固这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess cancer risk factors in incident systemic lupus erythematosus (SLE). METHODS: Clinical variables and cancer outcomes were assessed annually among incident SLE patients. Multivariate hazard regression models (overall risk and most common cancers) included demographic characteristics and time-dependent medications (corticosteroids, antimalarial drugs, immunosuppressants), smoking, and the adjusted mean Systemic Lupus Erythematosus Disease Activity Index 2000 score. RESULTS: Among 1,668 patients (average 9 years follow-up), 65 cancers occurred: 15 breast, 10 nonmelanoma skin, 7 lung, 6 hematologic, 6 prostate, 5 melanoma, 3 cervical, 3 renal, 2 each gastric, head and neck, and thyroid, and 1 each rectal, sarcoma, thymoma, and uterine cancers. Half of the cancers (including all lung cancers) occurred in past/current smokers, versus one-third of patients without cancer. Multivariate analyses indicated that overall cancer risk was related primarily to male sex and older age at SLE diagnosis. In addition, smoking was associated with lung cancer. For breast cancer risk, age was positively associated and antimalarial drugs were negatively associated. Antimalarial drugs and higher disease activity were also negatively associated with nonmelanoma skin cancer risk, whereas age and cyclophosphamide were positively associated. Disease activity was associated positively with hematologic and negatively with nonmelanoma skin cancer risk. CONCLUSION: Smoking is a key modifiable risk factor, especially for lung cancer, in SLE. Immunosuppressive medications were not clearly associated with higher risk except for cyclophosphamide and nonmelanoma skin cancer. Antimalarials were negatively associated with breast cancer and nonmelanoma skin cancer risk. SLE activity was associated positively with hematologic cancer and negatively with nonmelanoma skin cancer. Since the absolute number of cancers was small, additional follow-up will help consolidate these findings.
引用
- Bernatsky S, Ramsey-Goldman R, Urowitz MB, et al. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications. Arthritis Care Res (Hoboken). 2021. PMID: 32813314. doi:10.1002/acr.24425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。